Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Liver Disease Diagnosis and Treatment

Liver Disease Diagnosis and Treatment is a research topic within Epidemiology. Science Explorer counts 122k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, diagnosis, management, and pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). It covers topics such as liver fibrosis, insulin resistance, hepatic steatosis, metabolic syndrome, nonalcoholic steatohepatitis (NASH), and non-invasive assessment methods. The papers also discuss the association of NAFLD with hepatocellular carcinoma and its impact on public health.

  • NAFLD
  • NASH
  • Liver Fibrosis
  • Insulin Resistance
  • Hepatic Steatosis
  • Liver Biopsy
  • Metabolic Syndrome
  • Fatty Liver
  • Hepatocellular Carcinoma
  • Non-invasive Assessment
Research works
122k
fractional, since 1950
In the world top 10%
12k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+25%
the tick is no change
Largest producer
China
35% of the 10 largest, 2022-now
Liver Disease Diagnosis and Treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Liver Disease Diagnosis and Treatment research?

By volume, China and the United States publish the most (6.5k and 4.5k works in 2022-now).

By volume, 2022-now

  1. 1 China 6.5k works
  2. 2 United States 4.5k works
  3. 3 India 2k works
  4. 4 Japan 1k works
  5. 5 Italy 893 works
  6. 6 South Korea 873 works
  7. 7 Egypt 837 works
  8. 8 United Kingdom 816 works
  9. 9 Germany 735 works
  10. 10 Spain 585 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 34.8%United States: 23.8%India: 10.6%Japan: 5.4%6 others listed: 25.3%35%largest
China6,515 · 34.8%United States4,454 · 23.8%India1,982 · 10.6%Japan1,008 · 5.4%6 others listed4,738 · 25.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Liver Disease Diagnosis and Treatment research?

By volume in 2022-now, Sun Yat-sen University publishes the most Liver Disease Diagnosis and Treatment research, followed by Capital Medical University and Harvard University.

Who are the leading researchers in Liver Disease Diagnosis and Treatment?

The most-cited researchers publishing on Liver Disease Diagnosis and Treatment include Douglas G. Altman, Ahmedin Jemal and Christopher J L Murray.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Christopher J L Murray United States 583k citations
  4. 4 Freddie Bray France 550k citations
  5. 5 Eric S. Lander United States 524k citations
  6. 6 Zhong Lin Wang United States 491k citations
  7. 7 Jacques Ferlay France 486k citations
  8. 8 Rob Knight United States 468k citations
  9. 9 Simon Iain Hay United States 452k citations
  10. 10 George Davey Smith United Kingdom 435k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Liver Disease Diagnosis and Treatment?

The most cited paper in Liver Disease Diagnosis and Treatment is "Phosphorus Assay in Column Chromatography" (Grant R. Bartlett, 1959), with 12,866 citations. Next come "Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes" (11,032) and "Design and validation of a histological scoring system for nonalcoholic fatty liver disease†" (10,904).

Most cited papers
#PaperReleasedCitations
1 Phosphorus Assay in Column Chromatography Grant R. Bartlett · Journal of Biological Chemistry Open access Mar 1959 12,866
2 Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif et al. · Hepatology 28 Dec 2015 11,032
3 Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David Erwin Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology 24 May 2005 10,904
4 Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator Jack Bowden, George Davey Smith, Philip Haycock et al. · Genetic Epidemiology Open access 7 Apr 2016 9,855
5 The metabolic syndrome—a new worldwide definition K. G. M. M. Alberti, Paul Zimmet, Jonathan Edward Shaw · The Lancet Sep 2005 9,351
All 97 most cited papers, with filters and sorting

Where is Liver Disease Diagnosis and Treatment research done?

The largest centres of Liver Disease Diagnosis and Treatment research in 2022-now are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Shibīn al Kawm.

Largest cities, 2022-now

  1. 1 BeijingChina 794 works
  2. 2 ShanghaiChina 550 works
  3. 3 SeoulSouth Korea 470 works
  4. 4 GuangzhouChina 447 works
  5. 5 HangzhouChina 294 works
  6. 6 NanjingChina 282 works
  7. 7 LondonUnited Kingdom 257 works
  8. 8 ChengduChina 251 works
  9. 9 CairoEgypt 231 works
  10. 10 WuhanChina 228 works

Where it is the local speciality

  1. Shibīn al KawmEG · 65.0 works11×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Liver Disease Diagnosis and Treatment than the world average.

See Liver Disease Diagnosis and Treatment on the map

Where is the best place to study Liver Disease Diagnosis and Treatment?

Among universities, judged by research, University of California San Diego, Harvard University and Wenzhou Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.01%fractional works in this field (log) →share of work in the world top 10% →University of Califo…Karolinska InstitutetWenzhou Medical Univ…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of California San DiegoUnited States 76.231.0%3.3×74 +11.0%
2Harvard UniversityUnited States 67.218.4%2.1×156 +4.5%
3Wenzhou Medical UniversityChina 63.120.7%7.6×89 +87.9%
4Karolinska InstitutetSweden 62.423.1%3.6×48 +31.2%
5Zhejiang UniversityChina 62.216.1%2.2×141 +20.0%
6Sun Yat-sen UniversityChina 61.611.5%3.8×184 +25.1%
7Shanghai Jiao Tong UniversityChina 60.616.4%2.2×149 +16.4%
8Shanghai University of Traditional Chinese MedicineChina 60.515.3%15.1×97 +75.1%
9Sichuan UniversityChina 59.614.3%2.8×147 +59.9%
10National University of SingaporeSingapore 59.023.3%1.6×45 +41.7%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Liver Disease Diagnosis and Treatment, country by country

Is Liver Disease Diagnosis and Treatment research growing?

Output in 2022-2025 was 25% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Liver Disease Diagnosis and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Liver Disease Diagnosis and Treatment as a percentage of every work published that year, 0.13% in 2024.

still counting0.050%0.10%0.15%Liver Disease Diagnosis and Treatment0.12% in 202519801990200020102020

Fractional works of Liver Disease Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Liver Disease Diagnosis and Treatment10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Liver Disease Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.